welcome to DuchenneXchange- a positively charged Duchenne muscular dystrophy community.
- join today!
Prognostic Factors Affecting Duchenne Muscular Dystrophy
study id #: NCT03372655
condition: Duchenne Muscular Dystrophy
status: not yet recruitingpurpose:
Determination of prognostic factors affecting ambulation of duchenne muscular dystrophy
mechanism of action: No pharmaceutical intervention
last updated: November 22, 2018
start date: January 1, 2018
estimated completion: January 1, 2019
size / enrollment: 82
Duchenne muscular dystrophy is the most common herditary muscular disease , it lead to loss of ambulation in early teenageers . It lead to early death at the mean age of 19 years
- Ten meter walking test [Time Frame: 2018 - 2019]
- Muscle strength [Time Frame: 2018- 2019]
Any male pt diagnosed as Duchenne muscular dystrophy by typical clinical picture & shooting serum CPK level & EMG study or biopsy & age 10 to 18yrs old
Female patient' age below 10 yrs old or above 18 yrs old. Patient with autoimmune disease or malignancy.
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular DystrophyThe primary objective of this study is t...
Endomysial Fibrosis, Muscular Inflammatory Response and Calcium Homeostasis Dysfunction in Duchenne Muscular Dystrop...Duchenne muscular dystrophy (DMD) is the...
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular DystrophyThis is an open-label study to assess th...
Studying Skeletal Muscle, Heart, and Diaphragm Imaging in Boys With Duchenne Muscular DystrophyBackground: - Duchenne muscular dystrop...
Targeted re-sequencing emulsion PCR panel for myopathies: Results in 94 casesBackground: Molecular diagnostics in th...
European Home Mechanical Ventilation RegistryThe European Home Mechanical Ventilation...
Myocardial Involvement in Carriers of Duchenne Muscular Dystrophy: An MRI-studyCarriers of Duchenne muscular dystrophy ...
“Watching time tick by…”: Decision making for Duchenne muscular dystrophy trialsObjective:This interview study explored ...
Clay Matthews Supports Duchenne Muscular Dystrophy and First Approved Treatmenthttps://www.youtube.com/watch?v=WPu5pGEF...
Neurology care, diagnostics, and emerging therapies of the patient with Duchenne muscular dystrophyDuchenne muscular dystrophy is the most ...
Catabasis Quarterly: Updates on edasalonexent and clinical trialsHappy New Year! As 2019 kicks off, our P...